Cargando…

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

Objective. Calcinosis is a major cause of morbidity in JDM and has previously been linked to anti-NXP2 autoantibodies, younger age at disease onset and more persistent disease activity. This study aimed to investigate the clinical associations of anti-NXP2 autoantibodies in patients with JDM stratif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tansley, Sarah L., Betteridge, Zoe E., Shaddick, Gavin, Gunawardena, Harsha, Arnold, Katie, Wedderburn, Lucy R., McHugh, Neil J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241891/ https://www.ncbi.nlm.nih.gov/pubmed/24987158 http://dx.doi.org/10.1093/rheumatology/keu259

Ejemplares similares

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis
por: Gunawardena, H, et al.
Publicado: (2009)

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study
por: Tansley, Sarah L, et al.
Publicado: (2014)

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
por: Tansley, Sarah L., et al.
Publicado: (2017)

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
por: Gunawardena, H, et al.
Publicado: (2008)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
por: Toplak, Natasa, et al.
Publicado: (2022)

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
por: Betteridge, Zoe E, et al.
Publicado: (2011)

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease
por: Moraitis, E, et al.
Publicado: (2013)

Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?
por: Tansley, Sarah L, et al.
Publicado: (2013)

Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
por: Gossez, Morgane, et al.
Publicado: (2015)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis
por: Rietveld, Anke, et al.
Publicado: (2021)

Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis
por: Soponkanaporn, S., et al.
Publicado: (2018)

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023)

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
por: Ceribelli, Angela, et al.
Publicado: (2012)

A rare case of NXP-2 positive dermatomyositis
por: Khan, Nariman, et al.
Publicado: (2021)

A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies
por: Ito, Mitsuru, et al.
Publicado: (2020)

NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation
por: Butt, Zeeshan, et al.
Publicado: (2017)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

46 Universal calcinosis in juvenile dermatomyositis: a case report
por: Bahaz, N, et al.
Publicado: (2022)

Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature
por: Xu, Yingjie, et al.
Publicado: (2021)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
por: Butt, Zeeshan, et al.
Publicado: (2018)

Clinical Images: Degos‐like lesions in association with NXP‐2 dermatomyositis
por: Alhassan, Eaman, et al.
Publicado: (2023)

Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
por: Orandi, Amir B., et al.
Publicado: (2018)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Regulatory B cell Il-10 production is diminished in juvenile dermatomyositis
por: Piper, Christopher, et al.
Publicado: (2014)

The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients
por: Tansley, Sarah L, et al.
Publicado: (2020)

Clinically inactive disease in juvenile dermatomyositis – a proposed revision to the printo criteria
por: Almeida, Beverley, et al.
Publicado: (2014)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer
por: Fushida, Natsumi, et al.
Publicado: (2021)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models
por: Deakin, Claire T, et al.
Publicado: (2020)

Tubuloreticular inclusions in juvenile dermatomyositis: a diagnostically useful marker?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy
por: Chinoy, Hector, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j98m1b9gl2v2boecqf9hiknja4